delayed gastric emptying glp 1 GLP-1 Agonist-Induced – A Clinical Pharmacology Perspective Reflections on the discovery GLP-1

To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth

Furthermore, in vitro studies revealed that exendin-4 alleviated neuronal damage induced by high glucose and oxidative stress, and in the icv-STZ-induced rat model, it improved learning and memory by downregulating GSK-3 activity, thereby reversing tau hyperphosphorylation and safeguarding hippocampal neurons from degeneration [102]

Plateaus & How To Push Through Its completely normal to hit weight loss plateaus, even when using effective medications like GLP-1s

Weight loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) are revolutionizing the landscape of metabolic health, but as they work to help you achieve your goals, they also profoundly affect your digestive system